AccuVein is a global leader in medical imaging solutions. The Company's breakthrough product, the AccuVein AV400 vein visualization device, allows health care professionals to see a map of peripheral veins on the skin's surface to help access or avoid veins. In recent studies the AV400 has been shown to increase the success of venipuncture procedures as well as reduce the escalation calls, costs and pain associated with an inability to cannulate. In addition, the Infusion Nurses Society, the main advisory body for starting IVs, requires the use of vein visualization for many patients.
The AccuVein AV400 helps to access veins for IV starts, blood draw and sclerotherapy procedures and avoid veins in surgery and cosmetic procedures. It is built on AccuVein's proprietary technology as embodied in its patent portfolio, which includes 21 patents covering a broad range of imaging and medical diagnostic technologies. AccuVein is in use at more than 3,000 hospitals and available for sale in 125 countries worldwide.